Stay updated on Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Sign up to get notified when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.

Latest updates to the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedThe page’s software revision has been updated from v3.5.3 to v3.5.4. This represents an incremental platform update rather than a modification to the study information presented on the page.SummaryDifference0.1%

- Check24 days agoNo Change Detected
- Check39 days agoChange DetectedClinicalTrials.gov’s page revision/version label was updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

- Check46 days agoChange DetectedThe page revision was updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check75 days agoChange DetectedRevision: v3.5.0 is now displayed on the page, replacing Revision: v3.4.3.SummaryDifference0.1%

- Check84 days agoChange DetectedThe page now shows Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check112 days agoChange DetectedRevision updated to v3.4.2, replacing the previous v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab ± Ipilimumab in Gastrointestinal Stromal Tumor Clinical Trial page.